These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 33773121)

  • 41. Different disease, same challenges: Social determinants of tuberculosis and COVID-19.
    Duarte R; Aguiar A; Pinto M; Furtado I; Tiberi S; Lönnroth K; Migliori GB
    Pulmonology; 2021; 27(4):338-344. PubMed ID: 33648891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the impact of COVID-19 on individuals and families affected by vascular anomalies: The VBF COVID-19 survey.
    Rozell-Shannon L; Leahy J; Levitin GM; Nocini R; Colletti G
    J Plast Reconstr Aesthet Surg; 2021 May; 74(5):1101-1160. PubMed ID: 33342742
    [No Abstract]   [Full Text] [Related]  

  • 43. Tuberculosis--challenges and opportunities.
    Jain RC
    Indian J Tuberc; 2011 Oct; 58(4):148-54. PubMed ID: 22533163
    [No Abstract]   [Full Text] [Related]  

  • 44. Programmatic management of multidrug-resistant tuberculosis: models from three countries.
    Furin J; Bayona J; Becerra M; Farmer P; Golubkov A; Hurtado R; Joseph JK; Keshavjee S; Ponomarenko O; Rich M; Shin S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1294-300. PubMed ID: 21669029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Countdown Global Mental Health 2030: data to drive action and accountability.
    Saxena S; Kline S
    Lancet Psychiatry; 2021 Nov; 8(11):941-942. PubMed ID: 34587476
    [No Abstract]   [Full Text] [Related]  

  • 46. New Zealand's COVID-19 elimination strategy.
    Baker MG; Kvalsvig A; Verrall AJ
    Med J Aust; 2020 Sep; 213(5):198-200.e1. PubMed ID: 32789868
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bad news on antibiotic resistance front].
    Nau JY
    Rev Med Suisse; 2014 Nov; 10(452):2290-1. PubMed ID: 25562982
    [No Abstract]   [Full Text] [Related]  

  • 48. Explaining covid-19 performance: what factors might predict national responses?
    Baum F; Freeman T; Musolino C; Abramovitz M; De Ceukelaire W; Flavel J; Friel S; Giugliani C; Howden-Chapman P; Huong NT; London L; McKee M; Popay J; Serag H; Villar E
    BMJ; 2021 Jan; 372():n91. PubMed ID: 33509924
    [No Abstract]   [Full Text] [Related]  

  • 49. Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.
    Migliori GB; Tiberi S; García-Basteiro AL; Duarte R
    Pulmonology; 2021; 27(2):94-96. PubMed ID: 33272908
    [No Abstract]   [Full Text] [Related]  

  • 50. Equitable access to COVID-19 vaccination: a distant dream?
    Lomazzi M; De Sousa L; Amofah G; Ricciardi W
    Eur J Public Health; 2020 Dec; 30(6):1039-1040. PubMed ID: 33027515
    [No Abstract]   [Full Text] [Related]  

  • 51. Getting health services to three million people with TB.
    Pérez H
    J Int AIDS Soc; 2014; 17(1):19079. PubMed ID: 24666595
    [No Abstract]   [Full Text] [Related]  

  • 52. Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings.
    Airhihenbuwa CO; Tseng TS; Sutton VD; Price L
    Prev Chronic Dis; 2021 Apr; 18():E33. PubMed ID: 33830913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shifting gears to control drug-resistant tuberculosis.
    Berkelman RL; Cassell GH; Whitney EA; Keshavjee S
    Clin Infect Dis; 2014 Sep; 59(6):908-10. PubMed ID: 24944229
    [No Abstract]   [Full Text] [Related]  

  • 54. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
    Mangia A; Albanese AP; Bourliére M; Craxi A; Dieterich D; Solomon S; Vanstraelen K; Hernandez C; Turnes J
    Adv Ther; 2021 Mar; 38(3):1397-1403. PubMed ID: 33590446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorry for the delay.
    Lange C; Chesov D; Konstantynovska O; Mandalakas AM; Udwadia Z
    Clin Microbiol Infect; 2021 Jul; 27(7):941-943. PubMed ID: 33823271
    [No Abstract]   [Full Text] [Related]  

  • 56. The COVID-19 Pandemic Converges With Kidney Policy Transformation: Implications for CKD Population Health.
    Tummalapalli SL; Warnock N; Mendu ML
    Am J Kidney Dis; 2021 Feb; 77(2):268-271. PubMed ID: 33171214
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Social determinants of multidrug-resistant tuberculosis: A scoping review and research gaps.
    Najafizada M; Rahman A; Taufique Q; Sarkar A
    Indian J Tuberc; 2021 Jan; 68(1):99-105. PubMed ID: 33641859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementing testing approaches for SARS-CoV-2 to address health disparities: lessons learned from sexually transmitted infections.
    Chu CT; Rogers BG; Maynard MA; Napoleon SC; Chan PA
    Sex Transm Infect; 2021 Mar; 97(2):81-83. PubMed ID: 33247000
    [No Abstract]   [Full Text] [Related]  

  • 60. In the south, if you give us lemons, we will make you lemonade.
    Garcia B; Christon L; Gray S;
    J Cyst Fibros; 2020 Sep; 19(5):842-843. PubMed ID: 32546432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.